In the study, we brought to light that ARHGEF2 was regulated by ER stress and marked up the invasion and migration abilities of HUVEC cells to promote angiogenesis and tumor growth, further participating in the resistance of HCC cells to molecularly targeted drugs mediated by ER stress. Here, ARHGEF2 is linked to hepatocellular carcinoma.